Comparative analysis of quality of life in patients treated with canagliflozine or DPP-IV inhibitor

The article investigates the value of canagliflozin in the management of type 2 diabetes mellitus from the perspective of a clinically-based patient-centred approach. It focusses on the outcomes of a 52-week double-blind, active-controlled study. The results of this clinical trial demonstrate that c...

Full description

Bibliographic Details
Main Authors: Nina A. Petunina, Anna L. Terekhova, Ekaterina V. Goncharova
Format: Article
Language:English
Published: Endocrinology Research Centre 2016-12-01
Series:Сахарный диабет
Subjects:
Online Access:https://www.dia-endojournals.ru/jour/article/view/7949